Press release
2025-2034 Gene Delivery Technologies Market Evolution: Disruptions, Innovations, and Untapped Opportunities
Gene Delivery Technologies Market
What Is the Expected CAGR for the Gene Delivery Technologies Market Through 2025?
The market for gene delivery technologies has experienced swift expansion in the past few years. The market value is projected to inflate from $3.79 billion in 2024 to $4.3 billion in 2025, showing a compound annual growth rate (CAGR) of 13.6%. Factors influencing the growth during the historic period encompass improved comprehension of genetic illnesses, breakthroughs in cell therapy, the advent of nanotechnology, increased instances of gene therapy trials, and a surge in research funding.
What's the Projected Size of the Global Gene Delivery Technologies Market by 2029?
The market size of gene delivery technologies is projected to experience swift expansion in the upcoming years, escalating to "$7.44 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 14.7%. The progression during the predicted period can be credited to advancements in precision medicine, improvements in regulatory frameworks, the flourishing of gene therapy, and the growth of non-viral delivery systems. Noteworthy trends during the estimated phase encompass applications in rare diseases, an increase in clinical trials, targeted drug delivery, cell therapy expansion, and the evolution of gene editing tools.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report
Top Growth Drivers in the Gene Delivery Technologies Industry: What's Accelerating the Market?
The growth of the gene delivery technologies market is anticipated to be driven by the burgeoning number of cell and gene therapies. These therapies, which aim to treat or cure diseases by modifying a patient's genetics and cells, owe their growth primarily to significant advancements in gene editing technologies. These technologies are integral to the formulation and commercialization of cell and gene treatments. For instance, data from the Association of the British Pharmaceutical Industry, a trade association based in the UK, indicated in August 2024 that the UK medicines regulator used to approve on average two ATMPs per year, but this is projected to increase to 10-15 approvals annually by 2030. Furthermore, the number of patients receiving these treatments in the UK may increase from 2,500 in 2021 to a potential 10,000 annually by 2028. Therefore, the rise in cell and gene therapies propels the gene delivery technologies market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10706&type=smp
What Trends Will Shape the Gene Delivery Technologies Market Through 2029 and Beyond?
The gene delivery technologies market is embracing innovation through advanced delivery methods. In February 2023, US-based Aera Therapeutics introduced PNP technology to target RNA molecules involved in disease, enabling personalized gene therapy by editing genes directly within patient cells.
What Are the Main Segments in the Gene Delivery Technologies Market?
The gene delivery technologies market covered in this report is segmented -
1) By Mode: Biological, Chemical, Physical
2) By Method: Ex Vivo, In Vivo, In Vitro
3) By Application: Gene Therapy, Cell Therapy, Vaccines, Research
Subsegments:
1) By Biological: Viral Vectors, Bacterial Vectors, Lipid Nanoparticles
2) By Chemical: Cationic Lipids, Polymers, Chemical Transfection Agents
3) By Physical: Electroporation, Microinjection, Gene Gun, Sonoporation
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10706&type=smp
Which Top Companies are Driving Growth in the Gene Delivery Technologies Market?
Major companies operating in the gene delivery technologies market include Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Hoffmann-La Roche AG, Catalent Inc., Avantor, Pfizer Inc., Becton dic*kinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Regenexxbio Inc., Beam Therapeutics Inc., Verve Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG
Which Regions Will Dominate the Gene Delivery Technologies Market Through 2029?
North America was the largest region in the gene delivery technologies market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10706
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025-2034 Gene Delivery Technologies Market Evolution: Disruptions, Innovations, and Untapped Opportunities here
News-ID: 4106276 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
